0001125345-21-000038.txt : 20210309
0001125345-21-000038.hdr.sgml : 20210309
20210309195558
ACCESSION NUMBER: 0001125345-21-000038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210309
DATE AS OF CHANGE: 20210309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peters Jeffrey Stuart
CENTRAL INDEX KEY: 0001706903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 21727738
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wf-form4_161533774001831.xml
FORM 4
X0306
4
2021-03-08
0
0001125345
MACROGENICS INC
MGNX
0001706903
Peters Jeffrey Stuart
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
General Counsel
Common Stock
2021-03-08
4
M
0
21749
11.50
A
21749
D
Common Stock
2021-03-08
4
S
0
21749
26.50
D
0
D
Employee stock option (right to buy)
11.5
2021-03-08
4
M
0
21749
0
D
2030-02-20
Common Stock
21749.0
65251
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.
This transaction was executed in multiple trades at prices ranging from $26.50 to $26.63. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.
/s/ Lynn Cilinski, Attorney-in-Fact
2021-03-09